Bl 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments (2015)
- Authors:
- USP affiliated authors: OLIVEIRA, HARLEY FRANCISCO DE - FMRP ; TONE, LUIZ GONZAGA - FMRP ; ANNICHINI, MARIA SOL BRASSESCO - FFCLRP
- Unidades: FMRP; FFCLRP
- DOI: 10.1097/CAD.0000000000000157
- Subjects: ANTINEOPLÁSICOS (DESENVOLVIMENTO); CITOTOXINAS; OSTEOSSARCOMA
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2015
- Source:
- Título: Anti-Cancer Drugs
- ISSN: 0959-4973
- Volume/Número/Paginação/Ano: v. 26, n. 1, p. 56-63, 2015
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
BOGADO, Rodrigo F. E. et al. Bl 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments. Anti-Cancer Drugs, v. 26, n. 1, p. 56-63, 2015Tradução . . Disponível em: https://doi.org/10.1097/CAD.0000000000000157. Acesso em: 01 abr. 2026. -
APA
Bogado, R. F. E., Pezuk, J. A., Oliveira, H. F. de, Tone, L. G., & Brassesco, M. S. (2015). Bl 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments. Anti-Cancer Drugs, 26( 1), 56-63. doi:10.1097/CAD.0000000000000157 -
NLM
Bogado RFE, Pezuk JA, Oliveira HF de, Tone LG, Brassesco MS. Bl 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments [Internet]. Anti-Cancer Drugs. 2015 ; 26( 1): 56-63.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1097/CAD.0000000000000157 -
Vancouver
Bogado RFE, Pezuk JA, Oliveira HF de, Tone LG, Brassesco MS. Bl 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments [Internet]. Anti-Cancer Drugs. 2015 ; 26( 1): 56-63.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1097/CAD.0000000000000157 - Electromagnetic fields at extremely low frequencies and the risk for childhood leukemia [Editorial]: do we have enough information to warrant this association?
- Interplay between the RNA binding‐protein Musashi and developmental signaling pathways
- TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemia
- Anticancer activity of 7-epiclusianone, a benzophenone from Garcinia brasiliensis, in glioblastoma
- Base excision repair inhibition by methoxyamine impairs growth and sensitizes osteosarcoma cells to conventional treatments
- The antiproliferative and pro-apoptotic effects of methoxyamine on pediatric medulloblastoma cell lines exposed to ionizing radiation and chemotherapy
- A foretaste for pediatric glioblastoma therapy: targeting the NF-kB pathway with DHMEQ
- Activator protein-1 inhibition by 3-[(dodecylthiocarbonyl) methyl]-glutamaride impairs invasion and radiosensitizes osteosarcoma cells in vitro
- Standardization of a resazurin-based assay for the evaluation of metabolic activity in oral squamous carcinoma and glioblastoma cells
- Efeitos do ácido elágico em linhagens de glioblastoma pediátrico
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
